Issue 1/2022
Content (15 Articles)
Early Worsening of Retinopathy in Type 1 and Type 2 Diabetes After Rapid Improvement in Glycaemic Control: A Systematic Review
Handan Akil, Jamie Burgess, Sarah Nevitt, Simon P. Harding, Uazman Alam, Philip Burgess
Healthcare Costs and Resource Utilization Associated with the Use of Empagliflozin Versus Other Antihyperglycemic Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Real-World Retrospective Cohort Analysis
Aditya Raju, Pratik Pimple, Dana Stafkey-Mailey, Eileen Farrelly, Sharash Shetty
Improved Glycemic Control Observed in Children with Type 1 Diabetes Following the Introduction of Smart Insulin Pens: A Real-World Study
Peter Adolfsson, Viktor Björnsson, Niels Væver Hartvig, Anne Kaas, Jonas Bech Møller, Elsa Ogionwo Lange
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
Pierre Gourdy, Riccardo C. Bonadonna, Nick Freemantle, Didac Mauricio, Dirk Müller-Wieland, Gregory Bigot, Celine Mauquoi, Alice Ciocca, Mireille Bonnemaire
Patient Preferences for Pharmacological Diabetes Treatment Among People with Diabetes in Spain: A Discrete Choice Experiment
Fernando Gómez-Peralta, María Mareque, Álvaro Muñoz, Mercedes Maderuelo, Miguel Ángel Casado
Gut Microbiome Activity Contributes to Prediction of Individual Variation in Glycemic Response in Adults
Hal Tily, Eric Patridge, Ying Cai, Vishakh Gopu, Stephanie Gline, Matvey Genkin, Haely Lindau, Alisson Sjue, Iordan Slavov, Ally Perlina, Niels Klitgord, Helen Messier, Momchilo Vuyisich, Guruduth Banavar
Insulin Pump Treatment in Adults with Type 1 Diabetes in the Capital Region of Denmark: Design and Cohort Characteristics of the Steno Tech Survey
Karen Rytter, Kristoffer P. Madsen, Henrik U. Andersen, Bryan Cleal, Eva Hommel, Mette A. Nexø, Ulrik Pedersen-Bjergaard, Timothy Skinner, Ingrid Willaing, Kirsten Nørgaard, Signe Schmidt
Comparing Real-World Effectiveness of Dulaglutide and Insulin as the First Injectable for Patients with Type 2 Diabetes: An Australian Single-Site Retrospective Chart Review
Jared A. Houssarini, Alan J. M. Brnabic, Marwan Obaid
Prognostic Value of Stress Hyperglycemia in Patients Admitted to Medical/Geriatric Departments for Acute Medical Illness
Raffaella Di Luzio, Rachele Dusi, Francesca Alessandra Barbanti, Pietro Calogero, Giulio Marchesini, Giampaolo Bianchi
Efficacy of Dulaglutide in Chinese Patients with Type 2 Diabetes and Different Glycemic Patterns: a Post-hoc Analysis of the Phase 3 AWARD-CHN2 Trial
Qifu Li, Qiqi Zhang, Rui Wang, Tianpei Hong
Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study)
William H. Polonsky, Riya Arora, Mads Faurby, João Fernandes, Andreas Liebl
Are There Different Viewpoints About the Management of Type 2 Diabetes Mellitus and Comorbidities? A Multidisciplinary Spanish Qualitative Research
Francesc-Xavier Cos, Ricardo Gómez-Huelgas, Fernando Gomez-Peralta
Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results
Cristian Guja, Francesco Giorgino, Lawrence Blonde, Amar Ali, Martin Prázný, Juris J. Meier, Elisabeth Souhami, Robert Lubwama, Chen Ji, Julio Rosenstock
Letter to the Editor Regarding “Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data from PERSIAN Cohort Study”
Samaneh Asgari, Davood Khalili, Yadollah Mehrabi, Farzad Hadaegh
A Response to the Letter to the Editor Regarding “Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data from PERSIAN Cohort Study” to the end of Study
Mohammad E. Khamseh, Sadaf G. Sepanlou, Reza Malekzadeh